Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 55154-8335

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-8335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (E8d56e08 0450 4b5e 88c9 Ebb12725b263 00)

Bag Label (E8d56e08 0450 4b5e 88c9 Ebb12725b263 00)
MIRTAZAPINE ORALLY DISINTEGRATING TABLETS, USP 15 mg is a drug that comes in unit dose tablets, with each orally disintegrating tablet containing 15 mg mirtazapine USP. The tablets contain crospovidone, mannitol, microcrystalline cellulose, aspartame, strawberry guarana flavor, natural and artificial peppermint flavor, colloidal silicon dioxide, and magnesium stearate. This drug is not child-resistant and is intended for institutional use only. The package includes a separate medication guide for personalized use, and it should be stored in a cool and dry place, away from light and moisture. It is advisable to see the product insert for prescribing information, precautions, and warnings. The text also provides instructions on how to remove the tablets from their blister pack.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.